The activity of pipemidic acid and piromidic acid against Escherichia coli in static culture and in conditions stimulating the treatment of bacterial cystitis.
D000892:Anti-Infective Agents, Urinary / Q000494:pharmacology* / Q000627:therapeutic use; D003556:Cystitis / Q000188:drug therapy*; D004352:Drug Resistance, Microbial; D004926:Escherichia coli / Q000187:drug effects*; D009268:Nalidixic Acid / Q000494:pharmacology; D009539:Nicotinic Acids / Q000494:pharmacology* / Q000627:therapeutic use; D010879:Piperazines / Q000494:pharmacology / Q000627:therapeutic use; D011759:Pyrrolidines / Q000494:pharmacology / Q000627:therapeutic use
D000892:Anti-Infective Agents, Urinary; D009539:Nicotinic Acids; D010879:Piperazines; D011759:Pyrrolidines; D009268:Nalidixic Acid